Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study
Ist Teil von
The Journal of infectious diseases, 2024-03, Vol.229 (Supplement_1), p.S84-S91
Ort / Verlag
United States: Oxford University Press
Erscheinungsjahr
2024
Quelle
Oxford Journals 2020 Medicine
Beschreibungen/Notizen
Abstract
Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.
Sprache
Englisch
Identifikatoren
ISSN: 0022-1899
eISSN: 1537-6613
DOI: 10.1093/infdis/jiad484
Titel-ID: cdi_proquest_miscellaneous_2886937355
Format
–
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von bX